Episodes

  • Ozempic and Cancer Risk — Uncover what the science really says with Dr. Ben Synth

    Ozempic and Cancer Risk — Uncover what the science really says with Dr. Ben Synth
    Apr 7 2026
    Join Dr. Ben Synth as he cuts through the clickbait to uncover the real science behind Ozempic and cancer risk. From misunderstood rat studies to unexpected protective effects, this series reveals why the truth is far more fascinating than the headlines. Subscribe now to separate fear from facts.

    Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV

    This content was created in partnership and with the help of Artificial Intelligence AI
    Show More Show Less
    1 min
  • Ozempic and Cancer Risk — What We Know - The Detection Trap

    Ozempic and Cancer Risk — What We Know - The Detection Trap
    Apr 7 2026
    Join host Ben Synth as we examine the "detection trap" — when heightened surveillance creates the illusion of drug danger. We explore why Ozempic's thyroid cancer warnings may reflect statistical artifacts rather than real risk, analyzing large-scale studies showing no significant increase. Learn how detection bias distorts medical headlines and reshapes cancer screening debates.

    Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV

    This content was created in partnership and with the help of Artificial Intelligence AI
    Show More Show Less
    26 mins
  • Ozempic and Cancer Risk — What We Know - The Cancer Shield Nobody Expected

    Ozempic and Cancer Risk — What We Know - The Cancer Shield Nobody Expected
    Apr 7 2026
    AI host Ben Synth explores emerging research suggesting GLP-1 drugs like Ozempic may reduce cancer risk despite thyroid tumor warnings. Studies show potential 17-39% lower rates for obesity-related cancers including colon, endometrial, and ovarian. Episode examines metabolic mechanisms, observational study limitations, and why drugs designed for diabetes might unexpectedly shield against cancer.

    Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV

    This content was created in partnership and with the help of Artificial Intelligence AI
    Show More Show Less
    24 mins
  • Ozempic and Cancer Risk — What We Know - The Rat Trap

    Ozempic and Cancer Risk — What We Know - The Rat Trap
    Apr 7 2026
    Join AI host Ben Synth as he explores the decades-long story behind Ozempic's black box thyroid cancer warning. Discover how rodent tumors from 1990s testing shaped today's prescription labels, why rat thyroid biology differs fundamentally from human biology, and what massive patient studies actually reveal about cancer risk versus emerging protective benefits.

    Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV

    This content was created in partnership and with the help of Artificial Intelligence AI
    Show More Show Less
    20 mins